Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELCOM: Intra-arterial Melphalan for Choroidal Melanoma
NCT05893654Phase 2Enrolling by invitation
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Start
- May 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in choroidal melanoma, sponsored by Hospital das Clínicas de Ribeirão Preto. Started May 2021; status: enrolling by invitation.
02
Drugs
melphalan
03
Conditions
choroidal melanoma
Beyond the preview
Go deeper on NCT05893654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05893654.